The first federal lawsuit regarding the alleged link between necrotizing enterocolitis (NEC) and cow’s milk-based infant formulas is scheduled to go before a jury in August 2025. This product liability lawsuit is part of a series of bellwether trials aimed at assessing how juries might respond to evidence and testimonies that could be relevant to numerous legal claims filed against the manufacturers of popular infant formulas, specifically Similac and Enfamil.
What is Necrotizing Enterocolitis?
Necrotizing enterocolitis (NEC) is a severe gastrointestinal condition that primarily affects premature infants. It occurs when harmful bacteria invade the intestinal walls, leading to inflammation and tissue death. In severe instances, this can result in perforations in the intestines, allowing bacteria to enter the abdominal cavity or bloodstream, which can be life-threatening.
Alleged Risks Associated with Cow’s Milk-Based Formulas
Research suggests that cow’s milk-based formulas, such as those produced by Abbott Laboratories (Similac) and Mead Johnson (Enfamil), may significantly increase the risk of NEC in preterm infants. Recent studies have found that formula-fed infants are more likely to develop NEC compared to those who receive a diet exclusively consisting of human milk. The protective properties of human milk, which help reduce inflammation and bacterial invasion, may explain this discrepancy.
The Impact of NEC on Affected Infants
The consequences of NEC can be dire. Many infants who develop this condition require emergency surgery while still in the neonatal intensive care unit (NICU). Some affected infants do not survive, and those who do may face long-term health complications, potentially including:
- Intestinal strictures: Narrowing of the intestines that can cause pain and difficulty in food passage.
- Short-gut syndrome: A condition that arises when parts of the bowel are surgically removed due to necrosis, leading to nutrient absorption issues.
NEC Lawsuits Alleging a Link to Infant Formula Products
The increasing awareness of the potential risks associated with cow’s milk-based formulas has led to a surge in product liability lawsuits against their manufacturers. Parents of infants who have suffered from NEC are alleging that these companies failed to adequately warn consumers about the potential health risks linked to their products.
Consolidation of Claims Against Infant Formula Manufacturers
Due to common legal questions and factual issues involved, all federal NEC lawsuits have been consolidated in the U.S. District Court for the Northern District of Illinois. This consolidation allows for coordinated pretrial discovery and the selection of a small group of representative claims for early trial dates, known as bellwether trials. These early trials are designed to provide insight into how juries may respond to the evidence presented throughout the litigation.
The Upcoming Infant Formula NEC Bellwether Trials
The first bellwether trial in the infant formula NEC lawsuit is set to begin on August 8, 2025, involving a claim filed by a Maryland mother, Keosha Diggs. She alleges that her child, referred to as “K.B.” in the lawsuit, developed NEC after being fed Similac and Enfamil products, resulting in severe, lifelong injuries. The court is expected to hear motions for summary judgment in this claim shortly before the trial begins.
A second bellwether trial is also in the works, involving claims from Alexis Inman, whose child died after consuming Enfamil shortly after birth. The outcomes of these infant formula NEC trials will be closely monitored, as they may influence settlement negotiations for the hundreds of additional claims pending against the formula manufacturers.
The Potential for Infant Formula NEC Settlements
As the bellwether trials unfold, there is a possibility that the formula manufacturers may seek to negotiate settlements to avoid the uncertainty of jury trials for the remaining NEC claims. The average payouts awarded in these early trials could set a precedent for future settlements, influencing how much Abbott and Mead Johnson may ultimately be required to pay.
The Broader Implications for Infant Nutrition
The ongoing litigation surrounding necrotizing enterocolitis and cow’s milk-based formula raises critical questions about the safety and nutritional adequacy of these products. Parents are increasingly concerned about the potential risks associated with feeding their premature infants cow’s milk-based formulas, leading to a heightened demand for transparency and safety in infant nutrition.
The Future of NEC Litigation
As the bellwether trials approach, the outcomes of these product liability lawsuits will likely shape the future of NEC litigation. If the trials reveal significant evidence against the manufacturers, it may prompt a wave of settlements and increased scrutiny of cow’s milk-based formula products.
The Need for Ongoing Research
The litigation surrounding NEC also underscores the need for continued research into the safety of infant formulas. Understanding the potential long-term effects of these products on vulnerable populations, such as premature infants, is essential for ensuring their health and well-being.
Baby Formula NEC Lawsuit Information
An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products, Journal of Pediatrics
Breast milk and neonatal necrotising enterocolitis , The Lancet
